Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies

📆 1/3/2019 10:29 PM

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

Heavy debt, faltering in 2018, and cracks in the deal: Bristol-Myers Squibb's $74 billion acquisition of Celgene combines 2 troubled companies.

📆 1/3/2019 10:29 PM
📰 CNBC

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 72%

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Write Comment

That's like merging Deutsche Bank and Commerzbank. Guess 1-(-1) = 2

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol-Myers takes $74 bln bet against the marketThere are good reasons to buy rival oncology giant Celgene. But cost cuts don’t cover the 54 pct premium and the target’s owners get the financial benefit. Bristol is hoping for luck in the courts and multiple regulatory approvals that Celgene’s shareholders were skeptical of.
Read more »